PHARMACOGENETICS OF RESPONSE TO DOPAMINERGIC THERAPY IN PATIENTS WITH PARKINSON'S DISEASE
- Autores: Fedosova A.S1, Shipilova N.N2
-
Afiliações:
- Lomonosov Moscow State University
- Pirogov Russian National Research Medical University
- Edição: Volume 15, Nº 3S (2020)
- Páginas: 151-152
- Seção: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/123108
- DOI: https://doi.org/10.23868/gc123108
- ID: 123108
Citar
Texto integral
![Acesso aberto](https://genescells.ru/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Texto integral
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
A. Fedosova
Lomonosov Moscow State University
Email: annetfedosova@yandex.ru
Faculty of Biology Moscow, Russia
N. Shipilova
Pirogov Russian National Research Medical UniversityMoscow, Russia
Bibliografia
- De Lau L. M. L., Breteler M. M.B. The Lancet Neurology. 2006; 5(6): 525-535.
- Weintraub D., Siderowf A.D., Potenza M.N. et al. Archives of neurology 2006; 63(7): 969-973.
Arquivos suplementares
![](/img/style/loading.gif)